Gilead Sciences Inc

{ "date": [ "202612", "202712", "202812" ], "revenue_estimate": [ 30208.74, 32010.06, 33696.74 ], "ebit_estimate": [ 14158.87, 15540.73, 16555.17 ], "ebitda_estimate": [ 16698.69, 17621.1, 18350.78 ], "net_income_estimate": [ 10692.86, 11922.63, 12857.88 ], "per_share_eps_estimate": [ 7.29, 8.14, 9.06 ], "eps_nri_estimate": [ 8.67, 9.64, 10.48 ], "dividend_estimate": [ 3.25, 3.32, 3.46 ], "book_value_per_share_estimate": [ 21.71, 25.12, 31.37 ], "pretax_income_estimate": [ 13462.89, 15040.79, 16370.02 ], "operating_cash_flow_per_share_estimate": [ 9.07, 9.68, 10.89 ], "roa_estimate": [ 15.63, 16.5, 16.57 ], "roe_estimate": [ 39.6, 34.87, 30.88 ], "gross_margin_estimate": [ 85.28, 85, 85.9 ], "operating_cash_flow_estimate": [ 11349.38, 12113.1, 13630.15 ], "pettm_estimate": [ 19.23, 17.21, 15.46 ], "long_term_growth_rate_mean": 8.98, "long_term_revenue_growth_rate_mean": "4.74", "future_per_share_eps_estimate_growth": 10.32, "future_eps_nri_estimate_growth": 8.98, "future_revenue_estimate_growth": 4.74, "future_ebit_estimate_growth": 14.67, "future_ebitda_estimate_growth": 10.04, "future_dividend_estimate_growth": 2.97, "future_net_income_estimate_growth": 14.42, "future_pretax_income_estimate_growth": 17.95, "future_book_value_per_share_estimate_growth": 19.28, "future_roa_estimate_growth": 4.82, "future_roe_estimate_growth": -8.98, "future_gross_margin_estimate_growth": 2.58, "future_operating_cash_flow_per_share_estimate_growth": 10.47 }

{ "date": [ "202603", "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 6904.36, 7402.44, 7721.87, 8188.91, 7210.6, 7636, 7927.9, 8499.55 ], "ebit_estimate": [ 3104.23, 3447.34, 3734.48, 3888.95, 3432.99, 3666.96, 4089.94, 4039.85 ], "ebitda_estimate": [ 3456.08, 4074.87, 4465.5, 4699.12, 4235, 4403, 4809, 5015 ], "net_income_estimate": [ 2382.84, 2599.29, 2869.72, 2954.57, 2782.46, 2966.57, 3282.59, 3227.84 ], "per_share_eps_estimate": [ 1.59, 1.78, 1.96, 2, 1.83, 1.98, 2.24, 2.19 ], "eps_nri_estimate": [ 1.9, 2.09, 2.31, 2.39, 2.14, 2.35, 2.58, 2.8 ], "dividend_estimate": [ 0.81, 0.8, 0.8, 0.8, 0.77, 0.77, 0.77, 0.77 ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ 2950.55, 3267.48, 3564.82, 3746.69, 3097.86, 3331.19, 3753.54, 3702.81 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 84.97, 85.15, 85.55, 85.69, 77.9, 79.8, 80.8, 79.5 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 19.11, 18.52, 18.03, 17.42, 17.03, null, null, null ], "long_term_growth_rate_mean": 8.98, "long_term_revenue_growth_rate_mean": "4.74", "future_per_share_eps_estimate_growth": 10.32, "future_eps_nri_estimate_growth": 8.98, "future_revenue_estimate_growth": 4.74, "future_ebit_estimate_growth": 14.67, "future_ebitda_estimate_growth": 10.04, "future_dividend_estimate_growth": 2.97, "future_net_income_estimate_growth": 14.42, "future_pretax_income_estimate_growth": 17.95, "future_book_value_per_share_estimate_growth": 19.28, "future_roa_estimate_growth": 4.82, "future_roe_estimate_growth": -8.98, "future_gross_margin_estimate_growth": 2.58, "future_operating_cash_flow_per_share_estimate_growth": 10.47 }